Search Results - "Wingerchuk, Dean M"

Refine Results
  1. 1

    Neuromyelitis Spectrum Disorders by Weinshenker, Brian G., MD, Wingerchuk, Dean M., MD

    Published in Mayo Clinic proceedings (01-04-2017)
    “…Abstract The understanding of neuromyelitis optica spectrum disorder (NMOSD) has evolved substantially since its initial description over a century ago. The…”
    Get full text
    Journal Article
  2. 2

    Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies by Wingerchuk, Dean M., MD, MSc, FRCP(C), Carter, Jonathan L., MD

    Published in Mayo Clinic proceedings (01-02-2014)
    “…Abstract Multiple sclerosis (MS) is a chronic inflammatory demyelinating central nervous system disease that typically strikes young adults, especially women…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease by Wingerchuk, Dean M, Weinshenker, Brian G

    Published in Multiple sclerosis (01-01-2012)
    “…Neuromyelitis optica (NMO) and NMO spectrum disorders (NMOSD) are associated with autoantibodies that target aquaporin-4 and, in many cases, multiple other…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Smoking: effects on multiple sclerosis susceptibility and disease progression by Wingerchuk, Dean M.

    “…Multiple sclerosis (MS) is associated with both genetic and environmental factors that influence disease susceptibility. Exposure to cigarette smoke is…”
    Get full text
    Book Review Journal Article
  8. 8

    Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study by Pittock, Sean J, Dr, Lennon, Vanda A, PhD, McKeon, Andrew, MD, Mandrekar, Jay, PhD, Weinshenker, Brian G, MD, Lucchinetti, Claudia F, MD, O'Toole, Orna, MD, Wingerchuk, Dean M, Dr

    Published in Lancet neurology (01-06-2013)
    “…Summary Background Complement activation after binding of an IgG autoantibody to aquaporin 4 (AQP4) is thought to be a major determinant of CNS inflammation…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders by Flanagan, Eoin P, Weinshenker, Brian G, Krecke, Karl N, Lennon, Vanda A, Lucchinetti, Claudia F, McKeon, Andrew, Wingerchuk, Dean M, Shuster, Elizabeth A, Jiao, Yujuan, Horta, Erika S, Pittock, Sean J

    Published in JAMA neurology (01-01-2015)
    “…Short transverse myelitis (STM; <3 vertebral segments) is considered noncharacteristic of neuromyelitis optica (NMO) spectrum disorders (NMOSDs)…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension by Pittock, Sean J, Fujihara, Kazuo, Palace, Jacqueline, Berthele, Achim, Kim, Ho Jin, Oreja-Guevara, Celia, Nakashima, Ichiro, Levy, Michael, Shang, Shulian, Yountz, Marcus, Miller, Larisa, Armstrong, Róisín, Wingerchuk, Dean M

    Published in Multiple sclerosis (01-03-2022)
    “…During PREVENT (a phase 3, randomized, double-blind, placebo-controlled, time-to-event study) and its open-label extension (interim analysis), 33 adults with…”
    Get full text
    Journal Article
  13. 13

    The spectrum of neuromyelitis optica by Wingerchuk, Dean M, MD, Lennon, Vanda A, PhD, Lucchinetti, Claudia F, MD, Pittock, Sean J, MD, Weinshenker, Brian G, MD

    Published in Lancet neurology (01-09-2007)
    “…Summary Neuromyelitis optica (also known as Devic's disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica by Jiao, Yujuan, Fryer, James P., Lennon, Vanda A., Jenkins, Sarah M., Quek, Amy M.L., Smith, Carin Y., McKeon, Andrew, Costanzi, Chiara, Iorio, Raffaele, Weinshenker, Brian G., Wingerchuk, Dean M., Shuster, Elizabeth A., Lucchinetti, Claudia F., Pittock, Sean J.

    Published in Neurology (01-10-2013)
    “…OBJECTIVE:To 1) determine, using contemporary recombinant antigen–based assays, the aquaporin-4 (AQP4)–immunoglobulin G (IgG) detection rate in sequential sera…”
    Get full text
    Journal Article
  16. 16

    Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders by Mealy, Maureen A, Kim, Su-Hyun, Schmidt, Felix, López, Reydmar, Jimenez Arango, Jorge A, Paul, Friedemann, Wingerchuk, Dean M, Greenberg, Benjamin M, Kim, Ho Jin, Levy, Michael

    Published in Multiple sclerosis (01-11-2018)
    “…Background: Debate exists about whether neuromyelitis optica spectrum disorder seronegative disease represents the same immune-mediated attack on astrocytic…”
    Get full text
    Journal Article
  17. 17

    The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbations by Valencia-Sanchez, Cristina, Goodman, Brent P, Carter, Jonathan L, Wingerchuk, Dean M

    Published in Multiple Sclerosis Journal (01-05-2019)
    “…Diverse acute neurological injuries may cause acute cardiopulmonary events including neurogenic pulmonary edema (NPE) and neurogenic stunned myocardium (NSM)…”
    Get full text
    Book Review Journal Article
  18. 18

    A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis by Lennon, Vanda A, Wingerchuk, Dean M, Kryzer, Thomas J, Pittock, Sean J, Lucchinetti, Claudia F, Fujihara, Kazuo, Nakashima, Ichiro, Weinshenker, Brian G

    Published in The Lancet (British edition) (11-12-2004)
    “…Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is…”
    Get full text
    Journal Article
  19. 19

    Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis by Weinshenker, Brian G., Wingerchuk, Dean M., Vukusic, Sandra, Linbo, Linda, Pittock, Sean J., Lucchinetti, Claudia F., Lennon, Vanda A.

    Published in Annals of neurology (01-03-2006)
    “…Objective We investigated whether neuromyelitis optica (NMO) IgG seropositivity at the initial presentation of longitudinally extensive transverse myelitis…”
    Get full text
    Journal Article
  20. 20